Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists

Desmosterol acts as an endogenous RORγ agonist during differentiation of CD4+ T cells into the TH17 lineage, where there is increased cholesterol biosynthesis and uptake and decreased cholesterol metabolism and efflux that cause accumulation of desmosterol.